Cargando…
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
Autores principales: | de Paula, Bruno H R, Araújo, Indiara, Bandeira, Lívia, Barreto, Nathália M P B, Doherty, Gary J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252196/ https://www.ncbi.nlm.nih.gov/pubmed/32277907 http://dx.doi.org/10.1016/S1470-2045(20)30226-6 |
Ejemplares similares
-
Rethinking cancer clinical trials for COVID-19 and beyond
por: Doherty, Gary J., et al.
Publicado: (2020) -
Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
por: Abrams, Elissa Michele, et al.
Publicado: (2021) -
Health and economic implications of the ongoing coronavirus disease (COVID-19) pandemic on women and children in Africa
por: Yeboah, Helena, et al.
Publicado: (2023) -
Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk
por: Reza, Hasan Mahmud, et al.
Publicado: (2023) -
The European Space Agency’s Comet Interceptor lies in wait
por: Snodgrass, Colin, et al.
Publicado: (2019)